Tactogen has a total of 34 patents globally, out of which 1 have been granted. Of these 34 patents, more than 88% patents are active. The United States of America seems to be the main focused R&D centre and also is the origin country of Tactogen.
Tactogen was founded in 2020. Tactogen is a biopharmaceutical company that creates empathogen drugs. The company provides drug development methods, novel compounds, and pharmaceutical preparations to enable safer take-home prescription empathogens.
Do read about some of the most popular patents of Tactogen which have been covered by us in this article and also you can find Tactogen patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Tactogen patent portfolio.
How many patents does Tactogen have?
Tactogen has a total of 34 patents globally. These patents belong to 9 unique patent families. Out of 34 patents, 30 patents are active.
How Many Patents did Tactogen File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
| Year of Patents Filing or Grant | Tactogen Applications Filed | Tactogen Patents Granted |
| 2023 | 4 | 1 |
| 2022 | 6 | – |
| 2021 | 24 | – |
How many Tactogen patents are Alive/Dead?
Worldwide Patents
How Many Patents did Tactogen File in Different Countries?
Countries in which Tactogen Filed Patents
| Country | Patent |
| United States Of America | 4 |
| Europe | 4 |
| Canada | 4 |
| Australia | 4 |
| Taiwan | 3 |
| China | 3 |
| South Africa | 1 |
| Japan | 1 |
| Mexico | 1 |
| Israel | 1 |
Where are Research Centers of Tactogen Patents Located?
The Research Center of Tactogen is in the United States of America.
Best Tactogen Patent
US11767305B2 is the most popular patent in the Tactogen portfolio. It has received 1 citation so far from top company like Nec Corporation.
List of Tactogen patents
| Tactogen Patents | Title |
| US11767305B2 | Advantageous Benzofuran Compositions For Mental Disorders Or Enhancement |
| US20230257347A1 | Advantageous Tryptamine Compositions For Mental Disorders Or Enhancement |
| US20230183199A1 | 2-Aminoindane Compounds For Mental Disorders Or Enhancement |
| US20230159487A1 | Advantageous Benzothiophene Compositions For Mental Disorders Or Enhancement |
| EP4214192A1 | Advantageous Tryptamine Compositions For Mental Disorders Or Enhancement |
| EP4192447A1 | 2-Aminoindane Compounds For Mental Disorders Or Enhancement |
| EP4175638A1 | Advantageous Benzothiophene Compositions For Mental Disorders Or Enhancement |
| EP4161503A2 | Advantageous Benzofuran Compositions For Mental Disorders Or Enhancement |
| CN116209657A | 2-Aminoindane Compounds For Psychiatric Disorders Or Enhancement |
| CN116096715A | Beneficial Benzothiophene Compositions For Mental Disorders Or Mental Enhancement |
| CN116075300A | Advantageous Benzofuran Compositions For Mental Disorders Or Mental Enhancement |
| WO2023183613A3 | Indolizine Compounds For The Treatment Of Mental Disorders Or Inflammation |
| WO2023107653A3 | Benzofuran Salt Morphic Forms And Mixtures For The Treatment Of Mental Disorders Or Mental Enhancement |
| WO2023107715A1 | Specialized Combinations For Mental Disorders Or Mental Enhancement |
| WO2023081306A1 | Indolizine Compounds For The Treatment Of Mental Disorders Or Mental Enhancement |
| CA3192617A1 | Advantageous Tryptamine Compositions For Mental Disorders Or Enhancement |
| CA3187217A1 | 2-Aminoindane Compounds For Mental Disorders Or Enhancement |
| CA3182412A1 | Advantageous Benzothiophene Compositions For Mental Disorders Or Enhancement |
| CA3179785A1 | Advantageous Benzofuran Compositions For Mental Disorders Or Enhancement |
| AU2021343525A1 | Advantageous Tryptamine Compositions For Mental Disorders Or Enhancement |
| AU2021322291A1 | 2-Aminoindane Compounds For Mental Disorders Or Enhancement |
| AU2021305165A1 | Advantageous Benzothiophene Compositions For Mental Disorders Or Enhancement |
| AU2021289434A1 | Advantageous Benzofuran Compositions For Mental Disorders Or Enhancement |
| JP2023530092A | Benzofuran Composition Benefits For Psychosis Or Enhancement |
| IL298769A | Advantageous Benzofuran Compositions For Mental Disorders Or Enhancement |
| MX2022015613A | Benzofuran Compositions Beneficial For Mental Disorders Or Mental Improvement. |
| ZA202212974A | Advantageous Benzofuran Compositions For Mental Disorders Or Enhancement |
| TW202220965A | 2-Aminoindane Compounds For Mental Disorders Or Enhancement |
| TW202216676A | Advantageous Benzothiophene Compositions For Mental Disorders Or Enhancement |
| TW202216674A | Advantageous Benzofuran Compositions For Mental Disorders Or Enhancement |
| WO2022061242A1 | Advantageous Tryptamine Compositions For Mental Disorders Or Enhancement |
| WO2022032147A1 | 2-Aminoindane Compounds For Mental Disorders Or Enhancement |
| WO2021252538A3 | Advantageous Benzofuran Compositions For Mental Disorders Or Enhancement |
| WO2022010937A1 | Advantageous Benzothiophene Compositions For Mental Disorders Or Enhancement |
What are Tactogen key innovation segments?
What Technologies are Covered by Tactogen?
The chart below distributes patents filed by Tactogen